REFERENCES
- Bernal W, Auzinger G, Dhawan A, Acute liver failure. Lancet. 2010;376:190–201.
- Laleman W. Hemodynamic effects of albumin dialysis in patients with liver failure: for better or for worse? Ther Apher Dial. 2009;13:384–392.
- Stange M, Risler E, Lauchart G, Molecular adsorbent recycling system (MARS): clinical results of a new membrane-based blood purification system for bioartificial liver support. Artif Organs. 1999;23:319–330.
- Rifai K, Ernst T, Kretschmer U, Prometheus®—a new extracorporeal system for the treatment of liver failure. J Hepatol. 2003;39:984–990.
- Schmidt L, Wang L, Hansen B, Systemic hemodynamic effects of treatment with the molecular adsorbents recirculating system in patients with hyperacute liver failure: a prospective controlled trial. Liver Transpl. 2003;9:290–297.
- Tsai M. Extracorporal liver support with molecular adsorbents recirculating system in patients with hepatitis B associated fulminant hepatic failure. Int J Clin Pract. 2005;59:1289–1294.
- Taner C, Bathala V, Nguyen J. Primary nonfunction in liver transplantation: a single-center experience. Transpl Proc. 2008;40:3566–3568.
- Guo L, Liu J, Xu D, Application of molecular adsorbents recirculating system to remove NO and cytokines in severe liver failure patients with multiple organ dysfunction syndrome. Liver Int. 2003;23:16–20.
- Klammt S, Mitzner S, Stange J, Improvement of impaired albumin binding capacity in acute on chronic liver failure by albumin dialysis. Liver Transpl. 2008;14:1333–1339.
- Oettl K, Stadlbauer V, Petter F, Oxidative damage of albumin in advanced liver disease. Biochim Biophys Acta. 2008;1782:469–473.
- Kostopanagiotou G, Pandazi A, Andreadou I, Effects of mannitol in the prevention of lipid peroxidation during liver resection with hepatic vascular exclusion. J Clin Anesth. 2006;18:570–574.
- Orii R, Sugawara Y, Hayashida M, Effects of amrinone on ischaemia-reperfusion injury in cirrhotic patients undergoing hepatectomy: a comparative study with prostaglandin E1. Br J Anaesth. 2000;85:389–395.
- Schmidt L, Sørensen V, Svendsen L, Hemodynamic changes during a single treatment with the molecular adsorbents recirculating system in patients with acute-on-chronic liver failure. Liver Transpl. 2001;7:1034–1039.
- Sorkine P, Ben Abranham R, Szold O. Role of the molecular adsorbent recirculating system in the treatment of patients with acute exacerbation of chronic liver failure. Crit Med. 2001;29:1332–1336.
- Catalina M, Barrio J, Anaya F, Hepatic and systemic haemodynamic changes after MARS in patients with acute on chronic liver failure. Liver Int. 2003;23:39–43.
- Jalan R, Sen S, Steiner C, Extracorporeal liver support with molecular adsorbents recirculating system in patients with severe acute alcoholic hepatitis. J Hepatol. 2003;38:24–31.
- Glantzounis G, Salacinski H, Yang W, The contemporary role of antioxidant therapy in attenuating liver ischemia reperfusion injury: a review. Liver Transpl. 2005;11:1031–1047.
- Quinlan G, Martin G, Evans T. Albumin: biochemical properties and therapeutic potential. Hepatology. 2005;41:1211–1219.
- Sen S, Davies N, Mookerjee R, Pathophysiological effects of albumin dialysis in acute on chronic liver failure: a randomized controlled study. Liver Transpl. 2004;10:1109–1119.
- Staub F, Winkler A, Peters J, Swelling, acidosis, and irreversible damage of glial cells from exposure to arachidonic acid in vitro. J Cereb Blood Flow Metab. 1994;14:1030–439.
- Brahma B, Forman R, Stewart E, Ascorbate inhibits edema in brain slices. J Neurochem. 2000;74:1263–1270.
- Klammt S, Mitzner S, Stange J, Albumin-binding function is reduced in patients with decompensated cirrhosis and correlates inversely with severity of liver disease assessed by model for end-stage liver disease. Eur J Gastroenterol Hepatol. 2007;19:257–263.